ArticleCell death & disease2019

Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation.

Man-Hsin Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.